The Utility of PET/CT in the Planning of Stereotactic Body Radiotherapy for Non-small Cell Lung Cancer
NCT00380666 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2021-05-06
Summary
The trial evaluates the utility of 18FDG-PET/CT scan in the target definition process when SBRT is planned for stage I NSCLC.
Conditions
Interventions
- PROCEDURE
-
PET/CT scan
Sponsors & Collaborators
-
The Danish Medical Research Council
collaborator OTHER -
University of Aarhus
lead OTHER
Principal Investigators
-
Morten Hoyer, MD, PhD · Aarhus University Hospital
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-06-30
- Primary Completion
- 2010-07-31
- Completion
- 2010-07-31
More Related Trials
-
An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation
NCT01260480 ·Status: UNKNOWN ·Phase: PHASE2
-
Positron Emission Tomography Scan and CT Scan in Planning Radiation Therapy for Patients With Stage II or Stage III Non-Small Cell Lung Cancer
NCT00310219 ·Status: COMPLETED ·Phase: NA
-
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
NCT00004138 ·Status: COMPLETED ·Phase: NA
-
The Utility of FDG-PET for Radiation Treatment in NSCLC
NCT00385164 ·Status: UNKNOWN
-
FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung Cancer
NCT02995889 ·Status: COMPLETED ·Phase: NA
-
PET CT Re-Planning NSCLC (4DCT-PET)
NCT03403127 ·Status: COMPLETED ·Phase: NA
-
[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma
NCT04252859 ·Status: TERMINATED ·Phase: PHASE2
-
Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation Therapy
NCT03493789 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Study of 18F-FLT PET
NCT00585741 ·Status: TERMINATED ·Phase: NA
-
The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients
NCT06082492 ·Status: RECRUITING ·Phase: NA
-
FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy
NCT00424138 ·Status: TERMINATED ·Phase: NA
-
PET/CT Evaluation of Treatment Response in Breast Cancer
NCT01222416 ·Status: TERMINATED ·Phase: NA
-
Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PET
NCT00180154 ·Status: COMPLETED
-
Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial)
NCT00136864 ·Status: COMPLETED ·Phase: PHASE3
-
Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG
NCT06107374 ·Status: RECRUITING ·Phase: PHASE2
-
PET-DECT for Staging and Imaged Based Radiotherapy Planning in Lung Cancer
NCT03146117 ·Status: TERMINATED
-
Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung Cancers
NCT01421953 ·Status: COMPLETED ·Phase: NA
-
PET Imaging of Subjects Using 124I-PU-AD
NCT03371420 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated Atelectasis
NCT00184964 ·Status: UNKNOWN ·Phase: NA
-
Serial [18F]Fluorodeoxyglucose ([18F]FDG )PET/CT as a Biomarker of Therapeutic Response in Anti-PD1/PDL1 Therapy
NCT02608528 ·Status: TERMINATED
-
Research for the Molecular Imaging of the PD-L1 Targeting Tracer
NCT04304066 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
PET Imaging With [18F]F-AraG in Advanced Non-small Cell Lung Cancer (NSCLC)
NCT04524195 ·Status: TERMINATED ·Phase: PHASE1
-
Dual PET/CT Imaging in Lung Cancer
NCT01539928 ·Status: UNKNOWN
-
Radiotherapy Planning Based on Positron Emission Tomography With Fluoro-deoxyglucose For Advanced NSCLC
NCT00697333 ·Status: UNKNOWN ·Phase: PHASE2
-
PET With Respiratory Gating Technique in Evaluation of Response and Normal Tissue Effect in Thoracic Cancer
NCT02063633 ·Status: UNKNOWN